VTGN

SEC filing VTGN Appoints Angel S. Angelov as CMO, Grants 150,000 Share Option at $0.5955 Exercise Price

13d ago

News All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy

14d ago

SEC filing VTGN Receives FDA Study May Proceed for Refisolone IND, Phase 2 Hot Flash Program Enabled, 80% Frequency Reduction in Phase 2a Study

34d ago

SEC filing VTGN Announces Mary Rotunno Resignation Effective April 1, 2026

75d ago

News Dow Jones Futures: S&P 500 Rises To Resistance As Nvidia, ASML Lead; Carvana Dives Late, Walmart Due - Investor's Business Daily

103d ago

News Palantir Gets Partial Win in Fight With Ex-Workers at AI Startup

103d ago

News Stock Market Today, Feb. 18: Nvidia Rallies As Meta Deal Boosts AI Confidence

103d ago

News Stock Market Today, Feb. 18: Palantir Technologies Rises After Mizuho Upgrade Highlights AI Growth Potential - Nasdaq

103d ago

News Vistagen advances PALISADE-4 trial with $61.8M in cash while refining placebo mitigation strategies

109d ago

News Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

134d ago

News VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

134d ago

News Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN

134d ago

News SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Notifies Vistagen (VTGN) Investors of the Pending Class Action Lawsuit

135d ago

News רוזן, משרד עורכי דין מוביל לזכויות משקיעים, מעודד את משקיעי Vistagen Therapeutics, Inc לקבל ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך - VTGN

136d ago

News ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

136d ago

News VTGN Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vistagen Therapeutics, Inc.

136d ago

News VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit

136d ago

News Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors

136d ago

News DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics

136d ago

News Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (VTGN)

136d ago

News CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

155d ago

Scanner Unusual volume (z=162.4)

166d ago